Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins
“In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions”, says Mattias Perjos, CEO of Getinge.Growth was particularly strong in ventilators, where Getinge is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. Paragonix Technologies, Inc., which was acquired in Q3 2024, reported impressive growth in the quarter. The